SCHEMBL27147137

SCHEMBL27147137

Nc1ccc(C(=O)c2cc(N)cc(N)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.52
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
CA12 O43570 1/20 0.50
CA14 Q9ULX7 1/20 0.50
HPGD P15428 2/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 5/20 0.44
NPC1 O15118 3/20 0.44
POLB P06746 2/20 0.44
MITF O75030 1/20 0.44
PKM P14618 2/20 0.44
MAPT P10636 2/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
SRD5A2 P31213 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
APEX1 P27695 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940092 0.90 CA12 (0.53) PBRM1CA1CA2CA9CA12
SCHEMBL9097535 0.87 CA12 (0.59) PBRM1CA1CA2CA9CA12
SCHEMBL204877 0.87 CA12 (0.59) PBRM1CA1CA2CA9CA12
SCHEMBL62657 0.87 CA12 (0.59) PBRM1CA1CA2CA9CA12
SCHEMBL8196675 0.87 PBRM1 (0.50) PBRM1CA1CA2CA9HPGD
SCHEMBL24587796 0.86 LMNA (0.50) PBRM1CA1CA2HPGDHTT
SCHEMBL16752017 0.86 LMNA (0.50) PBRM1CA1CA2CA9CA12
SCHEMBL7184429 0.86 PBRM1 (0.44) PBRM1CA1CA2CA9CA12
SCHEMBL7194361 0.86 CNR1 (0.46) PBRM1CA1CA2CA9CA12
Hydrochloric Acid SCHEMBL8640288 0.85 CA12 (0.57) PBRM1CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-02-05 US disclosed
EP-4578892-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL Asahi Kasei Kabushiki Kaisha (JP) 2025-07-02 EP disclosed
WO-2024043285-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL 旭化成株式会社 2024-02-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL TAF1, TAF1L, TAF9 PBRM1 1239/4885CA1 400/4885CA2 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.